HoldingsChannel.com
All Stocks Held By Lion Point Capital LP
As of  12/31/2023, we find all stocks held by Lion Point Capital LP to be as follows, presented in the table below with each row detailing each Lion Point Capital LP position, ordered by largest to smallest position size. The all-stocks-held-by-Lion Point Capital LP table shows the entity held in the first column (click any entity to explore other funds holding positions), the share amount held, the share count change between the last two reporting periods, and finally the position size for all stocks held by Lion Point Capital LP as of the latest filing.

   EntityAmountChange
 09/30/2023 to 12/31/2023
Position Size
($ in 1000's)
SEMTECH CORP      $111,256
     SMTC2,577,855+125,000$56,481
     Call2,500,000UNCH$54,775
MARINUS PHARMACEUTICALS INC 2,134,337 -11,000 $23,200
     MRNS2,134,337-11,000$23,200
ARDELYX INC 1,151,667 -25,000 $7,140
     ARDX1,151,667-25,000$7,140
MILESTONE PHARMACEUTICALS IN 1,650,207 +1,200,000 $2,756
     MIST1,650,207+1,200,000$2,756
HARPOON THERAPEUTICS INC 228,900 +146,442 $2,603
     HARP228,900+146,442$2,603
BURGERFI INTERNATIONAL INC 2,745,938 UNCH $2,361
     BFI2,745,938UNCH$2,361
KINIKSA PHARMACEUTICALS LTD 130,691 UNCH $2,292
     KNSA130,691UNCH$2,292
INSMED INC 70,335 UNCH $2,180
     INSM70,335UNCH$2,180
BATTALION OIL CORPORATION 222,182 -158,709 $2,135
     BATL222,182-158,709$2,135
CYMABAY THERAPEUTICS INC 82,425 UNCH $1,947
     CBAY82,425UNCH$1,947
TRAVERE THERAPEUTICS INC      $1,372
     TVTX78,000UNCH$701
     NOTE 21,000,000UNCH$671
FENNEC PHARMACEUTICALS INC 110,000 UNCH $1,234
     FENC110,000UNCH$1,234
AVADEL PHARMACEUTICALS PLC 80,000 UNCH $1,130
     AVDL80,000UNCH$1,130
ENPHYS ACQUISITION CORP 78,125 +78,125 $834
     NFYS78,125+78,125$834
SYNDAX PHARMACEUTICALS INC 34,500 UNCH $746
     SNDX34,500UNCH$746
BLUEBIRD BIO INC 531,256 UNCH $733
     BLUE531,256UNCH$733
HUMACYTE INC 235,000 UNCH $667
     HUMA235,000UNCH$667
SERES THERAPEUTICS INC 340,761 -351,042 $477
     MCRB340,761-351,042$477
MIRUM PHARMACEUTICALS INC 13,500 -13,500 $399
     MIRM13,500-13,500$399
REPLIMUNE GROUP INC 42,500 +7,500 $358
     REPL42,500+7,500$358
LUMOS PHARMA INC 90,794 UNCH $289
     LUMO90,794UNCH$289
AMYLYX PHARMACEUTICALS INC 14,000 +14,000 $206
     AMLX14,000+14,000$206
AADI BIOSCIENCE INC 82,423 UNCH $166
     AADI82,423UNCH$166
ACLARIS THERAPEUTICS INC 115,898 UNCH $122
     ACRS115,898UNCH$122
MICROSOFT CORP 100 UNCH $38
     MSFT100UNCH$38
ALPHABET INC 100 UNCH $14
     GOOG100UNCH$14
BURGERFI INTERNATIONAL INC 2,083,438 UNCH <$1
     BFIIW2,083,438+2,083,438$0
ISHARES TR (IWM) +165,000 $-33,117
     Put165,000UNCH$33,117
CHEVRON CORP NEW $0 (exited)
     CVX0-46$0
DURECT CORP $0 (exited)
     DRRX0-427,455$0
SPDR S&P 500 ETF TRUST $0 (exited)
     Put0-50,000$0

See Summary: Lion Point Capital LP Top Holdings
See Details: Top 10 Stocks Held By Lion Point Capital LP

EntityShares/Amount
Change
Position Value
Change
NFYS +78,125+$834
AMLX +14,000+$206
EntityShares/Amount
Change
Position Value
Change
DRRX -427,455-$1,064
CVX -46-$8
SPY +50,000+$21,374
IWM +165,000+$29,162
EntityShares/Amount
Change
Position Value
Change
MIST +1,200,000+$1,360
HARP +146,442+$2,271
SMTC +125,000-$16,280
REPL +7,500-$241
BFI UNCH-$824
KNSA UNCH+$22
INSM UNCH+$404
CBAY UNCH+$718
TVTX UNCH+$27
FENC UNCH+$408
EntityShares/Amount
Change
Position Value
Change
MCRB -351,042-$1,169
BATL -158,709-$219
ARDX -25,000+$2,339
MIRM -13,500-$454
MRNS -11,000+$5,930
IWM UNCH-$3,955
BFIIW UNCH-$235
GOOG UNCH+$1
MSFT UNCH+$6
Size ($ in 1000's)
At 12/31/2023: $199,772
At 09/30/2023: $224,428

Lion Point Capital LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Lion Point Capital LP 13F filings. Link to 13F filings: SEC filings

All Stocks Held By Lion Point Capital LP | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.